[1]
|
Achkar, J.M. and Fries, B.C. (2010) Candida Infections of the Genitourinary Tract. Clinical Microbiology Reviews, 23, 253-273. https://doi.org/10.1128/CMR.00076-09
|
[2]
|
Zeng, J., Zong, L.L., Mao, T., Huang, Y.X. and Xu, Z.M. (2011) Distribution of Candida albican Genotype and Candida Species Is Associated with the Severity of Vulvovagianl Candidiasis. Journal of Southern Medical University, 31, 1649-1653.
|
[3]
|
Biswas, S., Van Dijck, P. and Datta, A. (2007) Environmental Sensing and Signal Transduction Pathways Regulating Morphopathogenic Determinants of Candida albicans. Microbiology and Molecular Biology Reviews, 71, 348-376.
https://doi.org/10.1128/MMBR.00009-06
|
[4]
|
Sobel, J.D., Brooker, D., Stein, G.E., Thomason, J.L., Wermeling, D.P., Bradley, B., et al. (1995) Single Oral Dose Fluconazole Compared with Conventional Clotrimazole Topical Therapy of Candida Vaginitis. Fluconazole Vaginitis Study Group. American Journal of Obstetrics & Gynecology, 172, 1263-1268.
https://doi.org/10.1016/0002-9378(95)91490-0
|
[5]
|
Mendling, W., Brasch, J., Cornely, O.A., Effendy, I., Friese, K., Ginter-Hanselmayer, G., Hof, H., Mayser, P., Mylonas, I., Ruhnke, M., Schaller, M. and Weissenbacher, E.R. (2015) Guideline: Vulvovaginal Candidosis (AWMF 015/072), S2k (Excluding Chronic Mucocutaneouscandidosis). Mycoses, 58, 1-15. https://doi.org/10.1111/myc.12292
|
[6]
|
Sweeten, K.M. and Eriksen, N.L. (1997) Chlorexidine versus Sterile Water Vaginal Wash during Labor to Prevent Peripartum Infection. American Journal of Obstetrics & Gynecology, 176, 426-430. https://doi.org/10.1016/S0002-9378(97)70510-6
|
[7]
|
Minozzi, M., Gerli, S., Di Renzo, G.C., Papaleo, E. and Ferrari, A. (2008) The Efficacy and Safety of a Single Dose of Polyhexamethylene Biguanide Gynaecologic Solution versus a Seven-Dose Regimen of Vaginal Clindamycin Cream in Patients with Bacterial Vaginosis. European Review for Medical and Pharmacological Sciences, 12, 59-65.
|
[8]
|
Gerli, S., Rossetti, D. and Di Renzo, G.C. (2003) A New Approach for the Treatment of Bacterial Vaginosis: Use of Polyhexamethylene Biguanide. A Prospective, Randomized Study. European Review for Medical and Pharmacological Sciences, 7, 127-130.
|
[9]
|
Gentile, A., Gerli, S. and Di Renzo, G.C. (2012) A New Non-Invasive Approach Based on Polyhexamethylene Biguanide Increases the Regression Rate of HPV Infection. BMC Clinical Pathology, 12, 17. https://doi.org/10.1186/1472-6890-12-17
|
[10]
|
Marelli, G., Papaleo, E., Origoni, M., Caputo, L. and Ferrari, A. (2005) Polyhexamethylene Biguanide for Treatment of External Genital Warts: A Prospective, Double-Blind, Randomized Study. European Review for Medical and Pharmacological Sciences, 9, 369-372.
|
[11]
|
Gerli, S., Bavetta, S. and Di Renzo, G.C. (2012) Antisepsis Regimen in the Surgical Treatment of HPV Generated Cervical Lesions: Polyhexamethylene Biguanide vs Chlorhexidine. European Review for Medical and Pharmacological Sciences, 16, 1994-1998.
|
[12]
|
Anderson, D.J., Marathe, J. and Pudney, J. (2014) The Structure of the Human Vaginal Stratum Corneum and Its Role in Immune Defense. American Journal of Reproductive Immunology, 71, 618-623. https://doi.org/10.1111/aji.12230
|
[13]
|
Brocklehurst, P. and Mindel, A. (1991) Recurrent Genital Infections. British Journal of Sexual Medicine, 18, 54-57.
|
[14]
|
Glover, D.D. and Larsen, B. (1998) Longitudinal Investigation of Candida Vaginitis in Pregnancy: Role of Superimposed Antibiotic Use. Obstetrics & Gynecology, 91, 115-118.
https://doi.org/10.1016/S0029-7844(97)00588-7
|
[15]
|
Monif, G.R.G. (1985) Pathogenesis and Classification of Vulvovaginal Candidiasis. American Journal of Obstetrics & Gynecology, 152, 935-939.
https://doi.org/10.1016/S0002-9378(85)80004-1
|
[16]
|
Thrumbore, D.J. and Sobel, J.D. (1986) Recurrent Vulvovaginal Candidiasis: Vaginal Epithelial Cells Susceptibility to Candida albicans Adherence. Obstetrics & Gynecology, 67, 810-812. https://doi.org/10.1097/00006250-198606000-00012
|
[17]
|
Gil-Bona, A., Parra-Giraldo, C.M., Hernáez, M.L., Reales-Calderon, J.A., Solis, N.V., Filler, S.G., Monteoliva, L. and Gil, C. (2015) Candida albicans Cell Shaving Uncovers New Proteins Involved in Cell Wall Integrity, Yeast to Hypha Transition, Stress Response and Host-Pathogen Interaction. Journal of Proteomics, 127, 340-351.
https://doi.org/10.1016/j.jprot.2015.06.006
|
[18]
|
Ruiz-Herrera, J., Elorza, M.V., Valentin, E. and Sentandreu, R. (2006) Molecular Organization of Cell Wall of Candida albicans and Its Relation to Pathogenicity. FEMS Yeast Research, 6, 14-29. https://doi.org/10.1111/j.1567-1364.2005.00017.x
|
[19]
|
Taylor, B.N., Staib, P., Binder, A., Biesemeier, A., Sehnal, M., et al. (2005) Profile of Candida albicans-Secreted Aspartic Proteinase Elicited during Vaginal Infection. Infection and Immunity, 73, 1828-1835. https://doi.org/10.1128/IAI.73.3.1828-1835.2005
|
[20]
|
Schaller, M., Borelli, C., Korting, H.C. and Hube, B. (2005) Hydrolytic Enzymes as Virulence Factors of Candida albicans. Mycoses, 48, 365-377.
https://doi.org/10.1111/j.1439-0507.2005.01165.x
|
[21]
|
Crowley, P.D. and Gallagher, H.C. (2014) Clotrimazole as a Pharmaceutical: Past, Present and Future. Journal of Applied Microbiology, 117, 611-617.
https://doi.org/10.1111/jam.12554
|
[22]
|
Bradbeer, C.S., Mayhew, S.R. and Barlow, D. (1985) Butoconazole and Miconazole in Treating Vaginal Candidiasis. Genitourinary Medicine, 61, 270-272.
https://doi.org/10.1136/sti.61.4.270
|
[23]
|
Stein, G.E., Gurwith, D., Mummaw, N. and Gurwith, M. (1986) Single-Dose Tioconazole Compared with 3-Day Clotrimazole Treatment in Vulvovaginal Candidiasis. Antimicrobic Agents and Chemotherapy, 29, 969-971. https://doi.org/10.1128/AAC.29.6.969
|
[24]
|
2015 Sexually Transmitted Diseases Treatment Guidelines.
|
[25]
|
Nurbhai, M., Grimshaw, J., Watson, M., Bond, C., Mollison, J. and Ludbrook, A. (2007) Oral versus Intra-Vaginal Imidazole and Triazole Anti-Fungal Treatment of Uncomplicated Vulvovaginal Candidiasis (Thrush). Cochrane Database System Review, 17, CD002845. https://doi.org/10.1002/14651858.cd002845.pub2
|
[26]
|
Das Neves, J., Pinto, E., Teixeira, B., Dias, G., Rocha, P., Cunha, T., Santos, B., Amaral, M.H. and Bahia, M.F. (2008) Local Treatment of Vulvovaginal Candidosis: General and Practical Considerations. Drugs, 68, 1787-1802.
https://doi.org/10.2165/00003495-200868130-00002
|
[27]
|
Hübner, N.O. and Kramer, A. (2010) Review on the Efficacy, Safety and Clinical Applications of Polihexanide, a Modern Wound Antiseptic. Skin Pharmacology and Physiology, 23, 17-27. https://doi.org/10.1159/000318264
|
[28]
|
McCauley, R.L., Linares, H.A., Pelligrini, V., Herndon, D.N., Robson, M.C. and Heggers, J.P. (1989) In Vitro Toxicity of Topical Antimicrobial Agents to Human Fibroblasts. Journal of Surgical Research, 46, 267-274. https://doi.org/10.1016/0022-4804(89)90069-3
|
[29]
|
Moore, K. and Gray, D. (2007) Using PHMB Antimicrobial to Prevent Wound Infection. Wounds UK, 3, 96-102.
|
[30]
|
Müller, G., Koburger, T. and Kramer, A. (2013) Interaction of Poly(Hexamethylene Biguanide) Hydrochloride (PHMB) with Phosphatidylcholine Containing O/W Emulsion and Consequences for Microbicidal Efficacy and Cytotoxicity. Chemico-Biological Interactions, 201, 58-64. https://doi.org/10.1016/j.cbi.2013.01.001
|
[31]
|
Choy, C.K., Cho, P. and Boost, M.V. (2013) Cytotoxicity of Rigid Gas-Permeable Lens Care Solutions. Clinical and Experimental Optometry, 96, 467-471.
https://doi.org/10.1111/cxo.12039
|
[32]
|
Broxton, P., Woodcock, P.M. and Gilbert, P. (1984) Binding of Polyhexamethylene Biguanides to the Cell Envelope of Escherichia coli. Microbios, 41, 15-22.
|
[33]
|
Ikeda, T., Tazuke, S. and Bamford, C.H. (1985) Interaction of Membrane Active Biguanides with Negatively Charged Species. A Model for Their Interaction with Target Sites in Microbial Membranes. Journal of Chemical Research, 6, 180-181.
|
[34]
|
Ikeda, T., Tazuke, S., Ledwith, A. and Bamford, C.H. (1985) Spectroscopic Studies on the Interaction of Polymeric In-Chain Biguanide Biocides with Phospholipid Membranes. Bulletin of the Chemical Society of Japan, 58, 705-709. https://doi.org/10.1246/bcsj.58.705
|
[35]
|
Gilbert, P. and Moore, L.E. (2005) Cationic Antiseptics: Diversity of Action under a Common Epithet. Journal of Applied Microbiology, 99, 703-715.
https://doi.org/10.1111/j.1365-2672.2005.02664.x
|
[36]
|
Yasuda, K., Ohmizo, C. and Katsu, T. (2003) Potassium and Tetraphenylphosphonium Ion-Selective Electrodes for Monitoring Changes in the Permeability of Bacterial Outer and Cytoplasmic Membranes. Journal of Microbiological Methods, 54, 111-115.
https://doi.org/10.1016/S0167-7012(02)00255-5
|
[37]
|
Ikeda, T., Tazuke, S. and Watanabe, M. (1983) Interaction of Biologically Active Molecules with Phos-Pholipid Membranes. Fluorescence Depolarization Studies on the Effect of Polymeric Biocide Bearing Biguanide Groups in the Main Chain. Biochimicaet Biophysica Acta, 735, 380-386. https://doi.org/10.1016/0005-2736(83)90152-9
|
[38]
|
Müller, G. and Kramer, A. (2008) Biocompatibility Index of Antiseptic Agents by Parallel Assessment of Antimicrobial Activity and Cellular Cytotoxicity. Journal of Antimicrobial Chemotherapy, 61, 1281-1287. https://doi.org/10.1093/jac/dkn125
|
[39]
|
Messick, C.R., Pendland, S.L., Moshirfar, M., Fiscella, R.G., Losnedahal, K.J., Schriever, C.A. and Schreckenberger, P.C. (1999) In-Vitro Activity of Polyhexamethylene Biguanide (PHMB) against Fungal Isolates Associated with Infected Keratitis. Journal of Antimicrobial Chemotherapy, 44, 297-298. https://doi.org/10.1093/jac/44.2.297
|